Target intelligence / Profile preview

Donor Human Leukocyte Antigen (HLA) and Recipient T-cell Receptor (TCR) Complex (HLA-TCR Complex)

Target
HLA-TCR Complex
Molecular classification
Receptor, Major Histocompatibility Complex (MHC), T-cell receptor (TCR), Protein complex
01

Overview

The interaction between donor Human Leukocyte Antigen (HLA) molecules and recipient T-cell receptors (TCR) is the fundamental immunological event in solid organ transplantation and hematopoietic stem cell transfer (Source: Murphy K, Weaver C. Janeway's Immunobiology. 9th ed. Garland Science; 2016). HLA molecules, also known as Major Histocompatibility Complex (MHC) proteins, are expressed on the surface of donor cells and present peptides to the recipient's T-cells (Source: NIH, National Institute of Allergy and Infectious Diseases). When the recipient's TCR recognizes the donor HLA-peptide complex as non-self—a process known as allorecognition—it triggers a robust immune response (Source: Ingulli E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol. 2010;25(1):61-74). This response leads to T-cell proliferation, cytokine production, and the eventual destruction of the transplanted tissue, manifesting as graft rejection (Source: Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363(15):1451-62). Conversely, in bone marrow transplants, donor T-cells may recognize recipient HLA, resulting in graft-versus-host disease (Source: Zeiser R, Blazar BR. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017;377(22):2167-2179). Therapeutic strategies targeting this interaction include broad immunosuppressants that inhibit downstream TCR signaling, such as calcineurin inhibitors, and more specific biologics like belatacept that block necessary costimulatory signals (Source: Vincenti F, et al. Belatacept and Long-Term Outcomes in Kidney Transplantation. N Engl J Med. 2016;374:333-343).

Other names
HLA-TCR interactionMHC-TCR complexAlloantigen-TCR complexDonor-recipient immune synapse
02

Mechanism of action

Inhibition of calcineurin-mediated T-cell activation, blockade of CD80/CD86-CD28 costimulation, depletion of T-lymphocytes, and inhibition of IL-2 receptor signaling.

03

Biological functions

Immune responseAntigen presentationAllorecognitionT-cell activationCytokine production
04

Disease associations

Transplant rejectionGraft-versus-host disease (GvHD)
05

Safety considerations

Increased risk of opportunistic infectionsPost-transplant lymphoproliferative disorder (PTLD)NephrotoxicityNeurotoxicityCytokine release syndromeGraft failure
06

Interacting drugs

Tacrolimus

7 more in the full profile.

07

Biomarkers

HLA-AHLA-BHLA-CHLA-DRB1Donor-specific antibodies (DSA)Panel Reactive Antibody (PRA)T-cell chimerism

Beyond the preview

Go deeper on Donor Human Leukocyte Antigen (HLA) and Recipient T-cell Receptor (TCR) Complex (HLA-TCR Complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Donor Human Leukocyte Antigen (HLA) and Recipient T-cell Receptor (TCR) Complex (HLA-TCR Complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call